Description
Cell-based assays screen more compounds and identify toxicity earlier in drug discovery
The EarlyTox™ Cardiotoxicity Kit provides a fast, simple, and reliable fluorescence-based method for identifying cardiotoxic compounds in a biorelevant assay using stem-cell derived cardiomyocytes. Leveraging our proprietary masking technology with our novel calcium sensitive indicator, researchers can:
- Eliminate cardiotoxic compounds and identify potential drug candidates
- Measure 384 samples in minutes rather than hours
- Minimize non-specific effect of dye on beat characteristics
- Reduce well-to-well variation and improve data quality
- Largest signal dynamic range available
- Benchmark against three reference compounds: isoproterenol, sotalol and propranolol